Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver FitzGerald

Showing results (51-60 of 288) with videos related to

Pageof 29
Sort By:
The Journal of Rheumatology|September 3, 2018
Modifications of Cardiovascular Risk Scores, But Not Standard Risk Scores, Improve Identification of Asymptomatic Coronary Artery Disease in Psoriatic ArthritisMuhammad Haroon, Agnes Szentpetery, Jonathan D Dodd, et al.
Biomedical Chromatography : BMC|September 19, 2003
The influence of alpha1-acid glycoprotein on collagenase-3 activity in early rheumatoid arthritisJ Louise Haston, Oliver FitzGerald, David Kane, et al.
Annals of the New York Academy of Sciences|July 13, 2002
Corticotropin-releasing hormone signaling in synovial tissue vascular endothelium is mediated through the cAMP/CREB pathwayAlice N McEvoy, Barry Bresnihan, Oliver Fitzgerald, et al.
Biomedical Chromatography : BMC|September 5, 2002
Preliminary observations on the influence of rheumatoid alpha-1-acid glycoprotein on collagen fibril formationJ Louise Haston, Oliver FitzGerald, David Kane, et al.
Clinical Rheumatology|January 20, 2020
Bristol rheumatoid arthritis fatigue scale is valid in patients with psoriatic arthritis and is associated with overall severe disease and higher comorbiditiesMuhammad Haroon, Agnes Szentpetery, Mohsin Ashraf, et al.
Clinical and Experimental Rheumatology|July 14, 2025
Harnessing extracellular vesicles for biomarker discovery in psoriatic diseaseConor R Bryan, Teresa Grohmann, Oliver FitzGerald, et al.
Arthritis and Rheumatism|April 13, 2004
Cyclooxygenase 2-derived prostaglandin E2 production by corticotropin-releasing hormone contributes to the activated cAMP response element binding protein content in rheumatoid arthritis synovial tissueAlice N McEvoy, Barry Bresnihan, Oliver FitzGerald, et al.
Seminars in Arthritis and Rheumatism|July 9, 2016
Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?Laura C Coates, Oliver FitzGerald, Philip S Helliwell, et al.
Clinical and Experimental Rheumatology|June 8, 2010
Fatigue is an independent outcome measure and is sensitive to change in patients with psoriatic arthritisPatricia Minnock, John Kirwan, Douglas Veale, et al.
Arthritis Research & Therapy|June 2, 2015
Early biomarkers of joint damage in rheumatoid and psoriatic arthritisAngela Mc Ardle, Brian Flatley, Stephen R Pennington, et al.
Pageof 29

Showing results (51-60 of 288) with videos related to

Sort By:
Pageof 29
The Journal of Rheumatology|September 3, 2018
Modifications of Cardiovascular Risk Scores, But Not Standard Risk Scores, Improve Identification of Asymptomatic Coronary Artery Disease in Psoriatic ArthritisMuhammad Haroon, Agnes Szentpetery, Jonathan D Dodd, et al.
Biomedical Chromatography : BMC|September 19, 2003
The influence of alpha1-acid glycoprotein on collagenase-3 activity in early rheumatoid arthritisJ Louise Haston, Oliver FitzGerald, David Kane, et al.
Annals of the New York Academy of Sciences|July 13, 2002
Corticotropin-releasing hormone signaling in synovial tissue vascular endothelium is mediated through the cAMP/CREB pathwayAlice N McEvoy, Barry Bresnihan, Oliver Fitzgerald, et al.
Biomedical Chromatography : BMC|September 5, 2002
Preliminary observations on the influence of rheumatoid alpha-1-acid glycoprotein on collagen fibril formationJ Louise Haston, Oliver FitzGerald, David Kane, et al.
Clinical Rheumatology|January 20, 2020
Bristol rheumatoid arthritis fatigue scale is valid in patients with psoriatic arthritis and is associated with overall severe disease and higher comorbiditiesMuhammad Haroon, Agnes Szentpetery, Mohsin Ashraf, et al.
Clinical and Experimental Rheumatology|July 14, 2025
Harnessing extracellular vesicles for biomarker discovery in psoriatic diseaseConor R Bryan, Teresa Grohmann, Oliver FitzGerald, et al.
Arthritis and Rheumatism|April 13, 2004
Cyclooxygenase 2-derived prostaglandin E2 production by corticotropin-releasing hormone contributes to the activated cAMP response element binding protein content in rheumatoid arthritis synovial tissueAlice N McEvoy, Barry Bresnihan, Oliver FitzGerald, et al.
Seminars in Arthritis and Rheumatism|July 9, 2016
Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?Laura C Coates, Oliver FitzGerald, Philip S Helliwell, et al.
Clinical and Experimental Rheumatology|June 8, 2010
Fatigue is an independent outcome measure and is sensitive to change in patients with psoriatic arthritisPatricia Minnock, John Kirwan, Douglas Veale, et al.
Arthritis Research & Therapy|June 2, 2015
Early biomarkers of joint damage in rheumatoid and psoriatic arthritisAngela Mc Ardle, Brian Flatley, Stephen R Pennington, et al.
Pageof 29